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Abstract
Background: Coexistence of splenic marginal zone lymphoma with hepatocellular carcinoma is
rare. Although some reports have suggested the possible pathogenic role of HBV, HCV, chronic
and persistent antigenic stimulation in lymphoma, their role in causing lymphomas is still unclear.
Case presentation: We describe a hepatocellular carcinoma with concomitant splenic marginal
zone lymphoma in a 64-year-old Chinese man with cirrhosis. Serum hepatitis B virus surface antigen
was positive and antihepatitis C virus antibody was negative. The resected liver mass measuring 4
× 3 × 3 cm was grey and soft with a small area of bleeding, necrosis and intact capsule. Cut surface
of the spleen was red-purple and had a diffuse reticulonodular appearance indicative of prominent
white pulp. On histologic sections, the liver mass was well and moderately differentiated
hepatocellular carcinoma, and the splenic tumor was a specific low-grade small B-cell lymphoma.
Immunohistochemical staining and gene rearrangement studies supported that the splenic tumor
represents a clonal B-cell lymphoma. Therefore, the diagnosis of SMZL was made from the splenic
specimen.
Conclusion:  To our knowledge, this is the second case report describing coexistence of
hepatocellular carcinoma and splenic marginal zone lymphoma in the course of chronic HBV
infection. However, we cannot assert at present that hepatitis B virus is directly involved in splenic
lymphomagenesis until more information is collected from more cases in the future.
Background
The frequency of primary lymphoma of the spleen is rela-
tively rare, although malignant lymphoma commonly
involves the spleen [1]. Splenic marginal zone lymphoma
(SMZL) is a distinctive and well-characterized B-cell neo-
plasm that involves the spleen and various organs [2].
Although SMZL is accepted as an entity in the World
Health Organization (WHO) classification [3], its his-
togenesis remains unclear. There are several reports of
simultaneous occurrence of additional cancers and SMZL
[4-6]. To our knowledge, only one reported patient who
had coexistent SMZL with hepatocellular carcinoma
(HCC) [4]. Here, we present a case report of SMZL with
coexistent HCC.
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Case presentation
Clinical history
A 64-year-old man was diagnosed 6 years earlier with cir-
rhosis secondary to chronic hepatitis B. He was noted to
have splenomegaly in a routine follow up. Laboratory
data were as follows: aspartate aminotransferase, 126 U/
litre (normal, < 40); alanine aminotransferase, 66 U/litre
(normal, < 36); alkaline phosphatase, 123 U/litre (nor-
mal, < 96); and γ-glutamyltransferase, 178 IU/litre (nor-
mal, < 96). Serum fetoprotein was 256 μg/litre (normal, <
20). Serum hepatitis B virus surface antigen was positive
and antihepatitis C virus antibody was negative.
Magnetic resonance imaging of the abdomen showed an
approximately 3.5 cm in diameter with a heterogeneous,
hypervascular enhancing mass in the left lateral segment
of the liver. A multiple, small-to-moderate nodules com-
posed of a low-density area throughout the parenchyma
was present in the enlarged spleen. There were no tumor
thrombi within the portal veins and lymphadenopathy
(Figure 1).
Positron emission tomography findings revealed the
ringed dense uptake of 18F-fluorodeoxyglucose in the
spleen. It was not absorbed in the lymph nodes of the
splenic hilus and behind the pancreatic head; there were
no abnormal hot areas in the liver.
After the liver tumor and spleen were resected, the serum
fetoprotein concentrations returned to within the normal
range. However, the patient who was treated symptomat-
ically and not treated with chemotherapy due to poor gen-
eral condition died 6 months after surgical resection.
Macroscopic and microscopic findings
Grossly, the resected liver tissue measured 10 × 7 × 5 cm.
There was a well circumscribed tumor measuring 4 × 3 ×
3 cm. The mass was grey and soft with a small area of
bleeding, necrosis and intact capsule. The non-tumorous
portion showed obvious cirrhotic nodularity. The resected
spleen measured 25 × 17 × 7.5 cm and weighed 1750 g.
The outer capsule was smooth, glistening, and intact. Cut
surface of the spleen was red-purple and had a diffuse
reticulonodular appearance indicative of prominent
white pulp. Splenic hilar and mesenteric lymph nodes
were not enlarged obviously.
On histologic sections, the tumor cells were growing in
cords of variable thickness, which were separated by sinu-
soid-like blood spaces in the liver mass. Diffuse fatty
Magnetic resonance imaging showed the tumor in the left lateral segment of the liver, and a multiple, small-to-moderate nod- ules in the enlarged spleen Figure 1
Magnetic resonance imaging showed the tumor in the left lateral segment of the liver, and a multiple, small-to-moderate nod-
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change of tumor cells was found in small area (Figure 2).
The non-tumour part showed cirrhotic change. The tumor
in the spleen was characterised by a micronodular lym-
phoid infiltrate located in white pulp, with variable red
pulp infiltration, marginal zone differentiation and follic-
ular replacement by neoplastic cells (Figure 3). The white
pulp tumoral nodules were composed of an inner central
zone of small lymphocytes, located in the mantle zone
and replacing the germinal center, and a peripheral zone
of medium-sized cells with clear cytoplasm and scattered
blasts (Figure 4), the marginal zone component. Splenic
hilar and mesenteric lymph nodes were not effaced with
intact capsules, sinuses, and germinal centers.
Immunohistochemical staining of the neoplastic cells
showed positivity for CD20, CD79α (Figure 5), Pax-5, bcl-
2 and lacked co-expression of cyclin D, CD30, CD3, CD5,
bcl-6, bcl-10, CD68, and cytokeratin, indicating that the
tumor was B-cell lymphoma. The proliferative index is
low, and Ki67 staining showed a distinctive annular pat-
tern, outlining the presence of an increased growth frac-
tion in the germinal center and marginal zone.
Amplification of Immunoglobulin heavy chain genes was
performed by semi-nested PCR, using primers directed to
the framework 2 (FR-2) region and to the joining region
(JH) as described previously [7,8] Gene rearrangement
studies also supported a clonal B-cell process with heavy
chain rearrangement (Figure 6).
Therefore, the liver mass was well and moderately differ-
entiated HCC, the diagnosis of SMZL was made from the
splenic specimen. The final pathological diagnosis was
coexistent SMZL with HCC in the course of chronic HBV
infection.
Discussion
Coexistence of splenic lymphoma with additional cancers
is rare. Iannitto et al [4] reported that twelve additional
cancers in a series of 129 patients consecutively diagnosed
with SMZL in three Italian centers. To our knowledge, this
is the second case report describing coexistence of HCC
and SMZL [4]. The B-cell nature of tumor cells in SMZL is
well known [2]. The neoplastic cells are medium sized
with roundish or slightly irregular nucleus, clumped chro-
matin, frequent small nucleolus, and a moderate amount
of cytoplasm with distinct borders sometimes of villous
The liver tumor showed a classic hepatocellular carcinoma arranged in trabecular and acinar patterns Figure 2
The liver tumor showed a classic hepatocellular carcinoma arranged in trabecular and acinar patterns. H&E, original magnifica-
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Morphology of Splenic marginal zone lymphoma Figure 4
Morphology of Splenic marginal zone lymphoma. Small lymphocytes, marginal zone cells and cells resembling monocytoid cells 
(H&E, original magnification ×400).
Morphology of Splenic marginal zone lymphoma Figure 3
Morphology of Splenic marginal zone lymphoma. Characteristic micronodular pattern in the SMZL centred in the white pulp, 
with variable red pulp infiltration (H&E, original magnification ×100).Diagnostic Pathology 2007, 2:5 http://www.diagnosticpathology.org/content/2/1/5
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appearance. Positivity for CD20, CD79a, Pax-5/BSAP,
IgM, and bcl2 are constantly observed. T-cell antigens are
always negative. Immunoglobulin heavy and light chain
genes are rearranged. Differential diagnosis with lympho-
plasmacytic lymphoma is more controversial, since SMZL
may show plasmacytic differentiation and serum mono-
clonal paraproteinaemia. Absence of CD10 and bcl-6
staining are useful for excluding follicular lymphoma, and
staining of cyclin D1 is helpful for excluding mantle cell
lymphoma.
Chronic hepatitis B virus (HBV) or hepatitis C virus
(HCV) infection is believed to play important roles in
hepatocarcinogenesis. As for primary lymphoma, its his-
togenesis remains obscure. Recently, some reports have
suggested the possible pathogenic role of HBV and HCV
[9-13]. It has been reported that chronic liver disease
accompanied primary lymphoma of the spleen in 14
(14.3%) of 98 cases [6]. Other models which may drive
and sustain malignant transformation include chronic
and persistent antigenic stimulation associated with
inflammation or autoimmune disease in lymphomagene-
sis. Antigen stimulation leads to a polyclonal T-cell
response promoting a B-cell monoclonal proliferation.
Eradication of the bacteria can lead to pathologic lym-
phoma regression in many cases [2,5,10]. However, their
role in causing lymphomas is still unclear. Therefore, we
cannot assert at present that hepatitis B virus is directly
involved in splenic lymphomagenesis until more infor-
mation is collected from more cases in the future.
Morphology of Splenic marginal zone lymphoma Figure 5
Morphology of Splenic marginal zone lymphoma. Tumor cells express CD79a (EnVision Plus, original magnification ×200).Diagnostic Pathology 2007, 2:5 http://www.diagnosticpathology.org/content/2/1/5
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